Category: Antibody Technologies
Global Antibody Technologies
-
Immunohistochemistry (IHC) Market Size, Share & Trends Analysis By Product, By Application, By End-Users, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
... 2030 According to SPER Market Research, the Immunohistochemistry Market is estimated to reach USD 5.8 billion by 2030 with a CAGR of 6.5%. Increase in geriatric population, prevalence of infectious disease, advanced technology, increase in ... Read More
-
Single-use Bioprocessing Market By Product (Bioreactors, Tangential-Flow Filtration Devices, Depth Filters, Disposable Filter Cartridges, Media Bags And Containers, Mixing Systems, Tubing Assemblies, Sampling Systems, Others), By Application (Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, Patient Specific Cell Therapies, Others), By Method (Filtration, Storage, Cell Culture, Mixing, Purification), By End User (Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research, Contract Research Organization & Manufacturers): Global Opportunity Analysis and Industry Forecast, 2020-2030
... Patient Specific Cell Therapies, Others), By Method (Filtration, Storage, Cell Culture, Mixing, Purification), By End User (Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research, Contract Research Organization & Manufacturers): Global Opportunity Analysis and Industry ... Read More
-
Hematological Malignancies Emerging Therapeutics Market - A Global and Regional Analysis: Focus on Therapeutic Type (Marketed), Potential Pipeline Products, Indication, and Region - Analysis and Forecast, 2021-2031
... Market Segmentation Marketed Drugs - Monoclonal Antibodies and CAR-T Cell Therapy Potential Pipeline Products - Monoclonal Antibodies and CAR-T Cell Therapy Indication - Leukemia, Lymphoma, and Multiple Myeloma Regional Segmentation North America - U.S. and ... Read More
-
Blood Plasma Derivatives Market by Product Type (Albumin, Anti-inhibitor Coagulation Factor, Factor VIII, Factor IX Concentrate, Immunoglobulins, Rh Immunoglobulin, Alpha 1-Protaese Inhibitor, and Anti–Thrombin), Application (HIV, Hemophilia A, Hemophilia B, Hepatitis C, Bleeding Disorders, Genetic Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
... Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global blood plasma derivatives market was valued at ... Read More
-
2022 Global Forecast for Neuroscience Antibodies & Assays (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
2022 Global: Custom Antibody - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
2022 Global Forecast for Immunoprecipitation (2023-2028 Outlook)-High Tech & Emerging Markets Report
... market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments value) ... Read More
-
2022 Global Forecast for Immunofluorescence Assay (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
2022 Global: Cell Signaling - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
2022 Global Forecast for Immunotherapy Drugs (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Blood Grouping Reagents Market Research Report: Information by Product (Consumables and Instruments), by Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), by Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, and Antigen Typing), by End User (Hospitals, Blood Banks, Clinical Laboratories) and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2027
... Tests, Antibody Identification, Coombs’s Test, and Antigen Typing), by End User (Hospitals, Blood Banks, Clinical Laboratories) and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2027 Blood Grouping Reagents Market ... Read More
-
Convalescent Plasma Therapy Global Market Report 2022 Including: 1) By Application: Prophylaxis; Treatment 2) By End-Users: Hospitals & Clinics; Laboratories & Research Institutes 3) By Antibody type: IgM; IgG; IgA Covering: Bio Farma; Grifols; Hilton Pharma; Biotest; BPL; LFB; Octapharma; CSL Behring; Takeda Pharmaceutical Company Limited; Orthosera Kft.
... focuses on convalescent plasma therapy market which is experiencing strong growth. The report gives a guide to the convalescent plasma therapy market which will be shaping and changing our lives over the next ten years ... Read More
-
Global Antibody Drug Conjugates (ADC); By Type (Cleavable Linker and Non-cleavable Linker), By Application (Blood Cancer (Leukemia, Multiple Myeloma, Lymphoma, Breast Cancer, Urothelial Cancer & Bladder Cancer and Others), By End Users (Research Institutes, Biotechnology Companies, Hospitals, and Clinics), By Region (North America, Europe, The Asia-Pacific (APAC), Latin America (LATAM), The Middle-East & Africa (MEA)) Trend Analysis, Competitive Market Share & Forecast, 2017-2027
... Companies, Hospitals, and Clinics), By Region (North America, Europe, The Asia-Pacific (APAC), Latin America (LATAM), The Middle-East & Africa (MEA)) Trend Analysis, Competitive Market Share & Forecast, 2017-2027 ADC Market Set for Promising Growth – ... Read More
-
Global GMP Cytokines Market Report, History and Forecast 2017-2028
... to be worth US$ 160.59 million in 2022 and is forecast to a readjusted size of US$ 385.92 million by 2028 with a CAGR of 15.73% during the review period. The global key manufacturers of ... Read More
-
Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery Including: 1) By Type: Monoclonal Antibodies (MAbs); Therapeutic Proteins; Vaccines 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others 3) By Route Of Administration: Oral; Parenteral; Others 4) By Drug Classification: Branded Drugs; Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs Covering: Merck & Co., Inc.; AbbVie Inc.; F. Hoffmann-La Roche AG; Johnson & Johnson; Pfizer Inc.
... market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 48 geographies. Understand how the market is ... Read More
-
Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), and End-User (Hospitals, Others, and Research Institutes)
... Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), and End-User (Hospitals, Others, and Research Institutes) The monoclonal antibody market is projected to reach US$ 243.05 billion by 2028 from US$ 111.01 billion in 2021; ... Read More
-
Chromatography Resins Market by Type (Hydrophobic Interaction Resin, Multimodal or Mixed-Mode Resin, Size Exclusion Resin, Affinity Resin, Ion-Exchange Resin, and Others) and Application (Antibody Purification, Biomolecule Separation & Purification, Vaccination, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
... and Industry Forecast, 2021–2030 The global chromatography resins market forecast was valued at $2.1 billion in 2020, and is projected to reach $4.1 billion by 2030, growing at a CAGR of 7.1% from 2021 to ... Read More
-
Global Custom Antibody Services Market - 2021-2028
... market size was valued US$ XX million in 2020 and is estimated to reach US$ XX million by 2028, growing at a CAGR of XX % during the forecast period (2021-2028). Market Dynamics Companies offering ... Read More
-
Global Cancer Monoclonal Antibodies Market - 2021-2028
... to cancer cells, as they bind to the proteins on their surface and stimulate an immune response. Therefore, monoclonal antibodies are highly customizable due to its specific nature and can play a crucial role in ... Read More
-
Next-Generation Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutic Area (Oncology and Autoimmune or Inflammatory) and Technology (Antibody-Drug Conjugates, Bispecific Antibodies, Fc Engineered Antibodies, Antibody Fragments and Antibody-Like Proteins, and Biosimilar Antibody Products
... Biosimilar Antibody Products The global next-generation antibody market is expected to reach US$ 12,050.13 million by 2028 from US$ 5,428.41 million in 2021; it is estimated to grow at a CAGR of 11.9% from 2021 ... Read More
-
Targeted Therapeutics Market - By Type (Monoclonal Antibodies, Small Molecular Inhibitors, Prodrug, And Nano-Particulate Antibody Conjugates), By Application (Breast Cancer, Leukemia, Colorectal Cancer, Lymphoma, Renal Cancer, Multiple Sclerosis, Wet Age-Related Macular Degeneration, And Lung Cancer), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, And Retail Pharmacies),And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030
... By Distribution Channel (Hospital Pharmacies, Online Pharmacies, And Retail Pharmacies),And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Targeted Therapeutics Market - ... Read More
-
Biopharmaceuticals Market by Product (Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, And Others) and by Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, And Others)- Global Opportunity Analysis and Industry Forecast 2022-2030
... Opportunity Analysis and Industry Forecast 2022-2030 The Biopharmaceuticals Market was valued at USD 345.84 billion in 2021 and is predicted to reach USD 974.48 billion by 2030 with a CAGR of 11.7% from 2022-2030. Biopharmaceutical ... Read More
-
COVID-19 Testing Market Update 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends
... has been changed, perhaps permanently. Hundreds of test products are on the market to detect the virus, both for its presence and immune response. And billions of dollars have been added to the in vitro ... Read More
-
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors
... (ACT) & IDO Inhibitors Within the cancer therapeutics space, which today is worth over $160 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for ... Read More
Research Assistance
